JHDAAI Recent Publications
Recent and forthcoming publications
JHDAAI faculty publish more than 50 peer-reviewed papers each year related to equity in drug access.
Below is a selection of recent publications.
Submitted for publication
- “Examining the Impact of Drug Company Settlements on Consumers’ Out-of-Pocket Expenditures and Total Claims Cost”
Antonio Trujillo, Jason Gibbons, Kiefer Ahn, Charles Bennett, Gerard Anderson
International Journal of the Economics of Business
- “Effects of Horizontal Mergers on Prices of Generic Drugs”
Antonio Trujillo, Mariana Socal, Gerard Anderson
Applied Economics Journal
- On the Motivation for Pharmaceutical Manufacturer Coupons: Brand Loyalty or Customer Acquisition?”
Jason Gibbons, Manuel Hermosilla, Antonio Trujillo
Health Services Research
- “The Role of Health Plan Type in Biosimilar Switching and Initiation”
Jeremy Costin, Morgane Mouslim, Mariana Socal, Antonio Trujillo
PharmacoEconomics
- “Do Patent Litigation Settlements Protect Weak Patents For Drugs?”
Kiefer Ahn, Antonio Trujillo, Jason Gibbons, Charles Bennett, Gerard Anderson
International Review of Law and Economics
Published in 2024
- “Drug Shortages – A Study in Complexity”
Mariana Socal, Joshua Sharfstein
JAMA Network Open, April 2024
- “Adjusting Starting Points for Initial Price Offers: The Example of Ibrutinib”
Jason Gibbons, Charles Bennett, Kenneth Carson, Gerard Anderson
American Journal of Managed Care, April 2024
- “Hospital and Physician Group Practice Participation in Prior and Next-Generation Value-Based Payment Programs”
So-Yeon Kang, Gerard Anderson
JAMA Network Open, February 2024
- “Congressional Investigation of RevAssist-Linked and General Pricing Strategies for Lenalidomide”
Charles Bennett, Jason Gibbons, Antonio Trujillo, Kenneth Carson, Kevin Knopf, Chadi Nabhan, Steven Rosen, David Aboulafia
JCO Oncology Practice, February 2024
- “Do Insurers With Greater Market Power Negotiate Consistently Lower Prices for Hospital Care? Evidence From Hospital Price Transparency Data”
Yang Wang, Mark Meiselbach, Jianhui Xu, Ge Bai, Gerard Anderson
Medical Care Research and Review, February 2024
- “Exploring the Influence of Health Insurance Plans on Biosimilar Adoption Rates”
Jeremy Costin, Morgane Mouslim, Mariana Socal, Antonio Trujillo
PharmacoEconomics Open, January 2024
- “Pediatric Drugs, Accelerated Approval, and Prospects for Reform”
Jeromie Ballreich, Hyung-Seok Kim, Mariana Socal
Pediatric Drugs, January 2024
- “Addressing the Drug-Shortage Crisis in Oncology”
Y. Tony Yang, Mariana Socal, Charles Bennett
JAMA Oncology, January 2024
- “Congressional Investigation of RevAssist-Linked and General Pricing Strategies for Lenalidomide”
Charles Bennett, Jason Gibbons, Antonio Trujillo, Kenneth Carson, Kevin Knopf, Chadi Nabhan, Steven Rosen, David Aboulafia
JCO Oncology Practice, January 2024
- “Characteristics of Prescription Drug Fills Using Pharmacy-Pharmacy Benefit Manager Discount Programs: The “GoodRx” Model”
Jill Curran, Yuchen Wang, So-Yeon Kang, Andrew Xuan, Gerard Anderson, Ge Bai, Caleb Alexander
Value in Health, January 2024